Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Fruman

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Frontiers in Oncology|August 19, 2021
Efficacy of a Novel Bi-Steric mTORC1 Inhibitor in Models of B-Cell Acute Lymphoblastic LeukemiaBianca J Lee, Sharmila Mallya, Nuntana Dinglasan, et al.
Nucleic Acids Research|February 2, 2023
Simultaneous inhibition of endocytic recycling and lysosomal fusion sensitizes cells and tissues to oligonucleotide therapeuticsBrendan T Finicle, Kazumi H Eckenstein, Alexey S Revenko, et al.
Blood|July 25, 2012
Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironmentZhihong Zeng, Yue Xi Shi, Twee Tsao, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|August 26, 2009
Organ-specific lymphangiectasia, arrested lymphatic sprouting, and maturation defects resulting from gene-targeting of the PI3K regulatory isoforms p85alpha, p55alpha, and p50alphaCarla Mouta-Bellum, Aleksander Kirov, Laura Miceli-Libby, et al.
British Journal of Cancer|December 15, 2020
Targeting eIF4F translation initiation complex with SBI-756 sensitises B lymphoma cells to venetoclaxLee-Or Herzog, Beth Walters, Roberta Buono, et al.
Nature Communications|July 5, 2020
Dietary glutamine supplementation suppresses epigenetically-activated oncogenic pathways to inhibit melanoma tumour growthMari B Ishak Gabra, Ying Yang, Haiqing Li, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 26, 2022
Nanocomplexes of doxorubicin and DNA fragments for efficient and safe cancer chemotherapySaad N Mohammad, Yeon Su Choi, Jee Young Chung, et al.
Oncotarget|July 9, 2016
MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem/ progenitor cellsZhihong Zeng, Rui-Yu Wang, Yi Hua Qiu, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Pitavastatin counteracts venetoclax resistance mechanisms in acute myeloid leukemia by depleting geranylgeranyl pyrophosphateRoberta Buono, Dennis Juarez, Madhuri Paul, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2013
Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell functionSharon Lim, Tzuen Yih Saw, Min Zhang, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Frontiers in Oncology|August 19, 2021
Efficacy of a Novel Bi-Steric mTORC1 Inhibitor in Models of B-Cell Acute Lymphoblastic LeukemiaBianca J Lee, Sharmila Mallya, Nuntana Dinglasan, et al.
Nucleic Acids Research|February 2, 2023
Simultaneous inhibition of endocytic recycling and lysosomal fusion sensitizes cells and tissues to oligonucleotide therapeuticsBrendan T Finicle, Kazumi H Eckenstein, Alexey S Revenko, et al.
Blood|July 25, 2012
Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironmentZhihong Zeng, Yue Xi Shi, Twee Tsao, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|August 26, 2009
Organ-specific lymphangiectasia, arrested lymphatic sprouting, and maturation defects resulting from gene-targeting of the PI3K regulatory isoforms p85alpha, p55alpha, and p50alphaCarla Mouta-Bellum, Aleksander Kirov, Laura Miceli-Libby, et al.
British Journal of Cancer|December 15, 2020
Targeting eIF4F translation initiation complex with SBI-756 sensitises B lymphoma cells to venetoclaxLee-Or Herzog, Beth Walters, Roberta Buono, et al.
Nature Communications|July 5, 2020
Dietary glutamine supplementation suppresses epigenetically-activated oncogenic pathways to inhibit melanoma tumour growthMari B Ishak Gabra, Ying Yang, Haiqing Li, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 26, 2022
Nanocomplexes of doxorubicin and DNA fragments for efficient and safe cancer chemotherapySaad N Mohammad, Yeon Su Choi, Jee Young Chung, et al.
Oncotarget|July 9, 2016
MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem/ progenitor cellsZhihong Zeng, Rui-Yu Wang, Yi Hua Qiu, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Pitavastatin counteracts venetoclax resistance mechanisms in acute myeloid leukemia by depleting geranylgeranyl pyrophosphateRoberta Buono, Dennis Juarez, Madhuri Paul, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2013
Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell functionSharon Lim, Tzuen Yih Saw, Min Zhang, et al.
Pageof 11